Clinical Retrospective Study on the Role of Spleen-Invigorating and Qi-Supporting Therapy in Non-Small Cell Lung Cancer Immunotherapy and Construction of Survival Prediction Model
The addition of TCM to PD‑1/PD‑L1 inhibitors prolongs PFS and OS in patients with stage IIIB-IV NSCLC. A survival prediction model based on routine clinical characteristics demonstrates predictive utility, offering a potential tool to inform clinical decision‑making.
Authors
- Zhi Wen (ORCID: https://orcid.org/0000-0001-6427-8034)
- Lihuai Wang (ORCID: https://orcid.org/0009-0007-4635-3230)
- Chun Shen (ORCID: https://orcid.org/0000-0002-9251-2382)
- Jiangnan Huang (ORCID: https://orcid.org/0000-0001-8678-6371)
- Hua Liu (ORCID: https://orcid.org/0000-0001-9141-5268)
- Ziyi Chen (ORCID: https://orcid.org/0000-0002-8093-8466)
- Yinhui Sun
- Yaoyao Li (ORCID: https://orcid.org/0000-0003-2421-1200)
Institutions
- Hunan University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Biological Procedures Online
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1186/s12575-025-00310-4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00